,14 Accumulating evidence has shown that lncRNAs drive cancer metabolic reprogramming by directly or indirectly interacting with key metabolic enzymes and regulatory molecules, further altering related metabolites and disrupting multiple metabolic pathways,15 including lncRNAs H19, NBR, and PVT1. This evidence concerns the gene H19 and cancer.